Post by Alira Health

invIOs INNOVATIVE IMMUNO-ONCOLOGY is an innovation-driven biotech company that develops first-in-class cell immunotherapy in oncology. The company needed to execute a Phase Ib multicenter clinical trial. Each patient required individualized manufacturing, release, and delivery of the drug product, creating a tightly coupled dependency between drug product manufacturing timelines and clinical site readiness. invIOs partnered with Alira Health’s CRO team to initiate and complete the trial efficiently, ensure the timely treatment of patients, and generate high-quality clinical data to support further development. If you’re tackling advanced therapies or complex early-phase trials, check out the case study below featuring invIOs. It demonstrates how the right execution model can turn operational challenges into measurable success.